| Trial ID: | L6033 |
| Source ID: | NCT00376038
|
| Associated Drug: |
Gsk189075 Oral Tablets
|
| Title: |
Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: GSK189075 oral tablets|DRUG: metformin tablets
|
| Outcome Measures: |
Primary: Blood concentrations of metformin when given with GSK189075 in T2DM subjects over 3-day course Lab tests, changes in blood pressure and heart rate and heart activity on EKG machine | Secondary: Blood levels of drugs at Day 3 Evaluation of efficacy and safety markers on Days 1, 2, and 3.
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
13
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-04
|
| Locations: |
GSK Investigational Site, Mexico, D.F., 14050, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT00376038
|
